The clinical significance of vimentin intermediate filament (VIF) expression was studied in relation to other established prognostic parameters in primary breast cancer. Archival tumour samples embedded in paraffin were examined by immunohistochemistry with monoclonal antibodies (MAbs) to VIF, p53 p
Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patients
β Scribed by Christian Parr; Chun H. Gan; Gareth Watkins; Wen G. Jiang
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 432 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0969-6970
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Vascular endothelial growth factor (VEGF) has emerged as one of the most important angiogenic growth factors from experimental __in vitro__ and __in vivo__ studies. In the present study, we investigated the relationship between VEGF expression and microvessel density (MVD) and defined t
## Abstract DNA microarrays have the potential to classify tumors according to their transcriptome. Tissue microarrays (TMAs) facilitate the validation of biomarkers by offering a highβthroughput approach to sample analysis. We reanalyzed a high profile breast cancer DNA microarray dataset containi
## Abstract HDAC genes are thought to be involved in gene expression through the regulation of chromatin structure, alterations of which may cause abnormal gene silencing in cancers. To clarify the possible role of HDAC genes during tumor development and progression, we studied their expression and
## Background: Vascular endothelial growth factor (vegf), a recently identified growth factor with significant angiogenic properties, is a multifunctional angiogenic cytokine that is expressed in many tumors. high vegf expression has been shown to correlate with the incidence of metastasis and poor